Vestcor Inc’s Corcept Therapeutics CORT Stock Holding History

Vestcor Inc’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	–	–	1217
2025 Q4	$0	Hold	4	–	–	﹤0.01%	1172
2025 Q3	$0	Sell	4 -11,122	-100%	-$805K	﹤0.01%	1193
2025 Q2	$817K	Buy	11,126 +3,961	+55%	+$287K	0.02%	551
2025 Q1	$818K	Sell	7,165 -551	-7%	-$33.5K	0.03%	496
2024 Q4	$389K	Hold	7,716	–	–	0.01%	770
2024 Q3	$357K	Hold	7,716	–	–	0.01%	820
2024 Q2	$251K	Hold	7,716	–	–	0.01%	877
2024 Q1	$194K	Hold	7,716	–	–	0.01%	973
2023 Q4	$251K	Buy	+7,716	New	+$212K	0.01%	906
2023 Q2	–	Sell	-3,705	Closed	-$80K	–	1090
2023 Q1	$80K	Hold	3,705	–	–	﹤0.01%	1029
2022 Q4	$75K	Hold	3,705	–	–	﹤0.01%	1093
2022 Q3	$95K	Buy	+3,705	New	+$99.1K	﹤0.01%	1080
2022 Q1	–	Sell	-6,010	Closed	-$119K	–	1450
2021 Q4	$119K	Sell	6,010 -4,190	-41%	-$85K	﹤0.01%	994
2021 Q3	$201K	Hold	10,200	–	–	0.01%	837
2021 Q2	$224K	Hold	10,200	–	–	0.01%	845
2021 Q1	$243K	Hold	10,200	–	–	0.01%	772
2020 Q4	$267K	Hold	10,200	–	–	0.01%	680
2020 Q3	$178K	Hold	10,200	–	–	0.01%	684
2020 Q2	$172K	Buy	+10,200	New	+$143K	0.01%	622

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vestcor Inc's CORT Position: Q1 2026 in Review

Vestcor Inc sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 4 shares.

Vestcor Inc first reported a position in CORT in Q2 2020 and held it in 19 quarters. The position peaked at $818K in Q1 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

Vestcor Inc reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
Vestcor Inc sold 4 Corcept Therapeutics shares in Q1 2026.
Vestcor Inc first reported a position in Corcept Therapeutics in Q2 2020 and held it in 19 quarters.
Vestcor Inc's Corcept Therapeutics position peaked at $818K in Q1 2025.
352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.